Literature DB >> 25293367

Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination.

Nathaniel D Lambert1, Iana H Haralambieva1, Richard B Kennedy1, Inna G Ovsyannikova1, Vernon Shane Pankratz2, Gregory A Poland3.   

Abstract

Vaccination with live attenuated rubella virus induces a strong immune response in most individuals. However, small numbers of subjects never reach or maintain protective antibody levels, and there is a high degree of variability in immune response. We have previously described genetic polymorphisms in HLA and other candidate genes that are associated with interindividual differences in humoral immunity to rubella virus. To expand our previous work, we performed a genome-wide association study (GWAS) to discover single-nucleotide polymorphisms (SNPs) associated with rubella virus-specific neutralizing antibodies. We identified rs2064479 in the HLA-DPB1 genetic region as being significantly associated with humoral immune response variations after rubella vaccination (P = 8.62 × 10(-8)). All other significant SNPs in this GWAS were located near the HLA-DPB1 gene (P ≤ 1 × 10(-7)). These findings demonstrate that polymorphisms in HLA-DPB1 are strongly associated with interindividual differences in neutralizing antibody levels to rubella vaccination and represent a validation of our previous HLA work.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  genetic; genome-wide association study; humoral; immunity; measles-mumps-rubella vaccine; neutralizing antibody; polymorphism

Mesh:

Substances:

Year:  2014        PMID: 25293367      PMCID: PMC4351364          DOI: 10.1093/infdis/jiu553

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Genomic control for association studies.

Authors:  B Devlin; K Roeder
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Robert A Vierkant; Megan M O'Byrne; Robert M Jacobson; Gregory A Poland
Journal:  Hum Hered       Date:  2011-11-11       Impact factor: 0.444

3.  Ongoing rubella outbreak among adolescents in Salaj, Romania, September 2011-January 2012.

Authors:  D Janta; A Stanescu; E Lupulescu; G Molnar; A Pistol
Journal:  Euro Surveill       Date:  2012-02-16

4.  Consistency of HLA associations between two independent measles vaccine cohorts: a replication study.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-25       Impact factor: 3.641

5.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

6.  A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population.

Authors:  Hamdi Mbarek; Hidenori Ochi; Yuji Urabe; Vinod Kumar; Michiaki Kubo; Naoya Hosono; Atsushi Takahashi; Yoichiro Kamatani; Daiki Miki; Hiromi Abe; Tatsuhiko Tsunoda; Naoyuki Kamatani; Kazuaki Chayama; Yusuke Nakamura; Koichi Matsuda
Journal:  Hum Mol Genet       Date:  2011-07-12       Impact factor: 6.150

7.  Genome-wide association study of antibody response to smallpox vaccine.

Authors:  Inna G Ovsyannikova; Richard B Kennedy; Megan O'Byrne; Robert M Jacobson; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2012-04-25       Impact factor: 3.641

8.  A qualitative and quantitative comparison of two rubella virus-specific IgG antibody immunoassays.

Authors:  Nicholas P Greenwood; Inna G Ovsyannikova; Robert A Vierkant; Megan M O'Byrne; Gregory A Poland
Journal:  Viral Immunol       Date:  2010-08       Impact factor: 2.257

9.  Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination.

Authors:  Iana H Haralambieva; Ann L Oberg; Inna G Ovsyannikova; Richard B Kennedy; Diane E Grill; Sumit Middha; Brian M Bot; Vivian W Wang; David I Smith; Robert M Jacobson; Gregory A Poland
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

10.  PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways.

Authors:  Anindya Bhattacharya; Jesse D Ziebarth; Yan Cui
Journal:  Nucleic Acids Res       Date:  2013-10-24       Impact factor: 16.971

View more
  21 in total

Review 1.  Vaccine-Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms.

Authors:  Paolo Pellegrino; Cristiana Perrotta; Emilio Clementi; Sonia Radice
Journal:  Drug Saf       Date:  2015-09       Impact factor: 5.606

2.  Genomics of immune response to typhoid and cholera vaccines.

Authors:  Partha P Majumder
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

Review 3.  Searching for the human genetic factors standing in the way of universally effective vaccines.

Authors:  Alexander J Mentzer; Daniel O'Connor; Andrew J Pollard; Adrian V S Hill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

Review 4.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

5.  Seroprevalence and durability of rubella virus antibodies in a highly immunized population.

Authors:  Stephen N Crooke; Iana H Haralambieva; Diane E Grill; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Vaccine       Date:  2019-05-21       Impact factor: 3.641

6.  Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.

Authors:  Emily A Voigt; Iana H Haralambieva; Beth L Larrabee; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

7.  Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Krista M Goergen; Diane E Grill; Min-Hsin Chen; Lijuan Hao; Joseph Icenogle; Gregory A Poland
Journal:  Vaccine       Date:  2019-11-12       Impact factor: 3.641

8.  Durability of humoral immune responses to rubella following MMR vaccination.

Authors:  Stephen N Crooke; Marguerite M Riggenbach; Inna G Ovsyannikova; Nathaniel D Warner; Min-Hsin Chen; Lijuan Hao; Joseph P Icenogle; Gregory A Poland; Richard B Kennedy
Journal:  Vaccine       Date:  2020-11-12       Impact factor: 3.641

Review 9.  Variability in Humoral Immunity to Measles Vaccine: New Developments.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Jennifer A Whitaker; Gregory A Poland
Journal:  Trends Mol Med       Date:  2015-11-18       Impact factor: 11.951

10.  Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Beth R Larrabee; Michael T Zimmermann; Diane E Grill; Daniel J Schaid; Gregory A Poland
Journal:  Hum Genet       Date:  2017-03-13       Impact factor: 5.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.